Well being employees attend to an mpox affected person at a remedy centre in Munigi, the Democratic Republic of the Congo
Related Press/Alamy
An mRNA vaccine for mpox developed by the biotech firm Moderna has proven promise in monkeys, elevating hopes that it may assist to sort out the continued outbreak in West and Central Africa. Whereas different vaccines for the virus exist already and helped to deliver a world mpox outbreak in 2022 below management, researchers say a brand new vaccine based mostly on mRNA expertise would have a number of benefits.
Nigeria, which has had 35 confirmed instances of mpox up to now…
Article amended on 9 September 2024
We corrected the virus used within the JYNNEOS vaccine.
